Attendere..
Cellecta Inc., a functional genomics solution provider, focuses primarily on developing and implementing flexible and scalable broad-based screening and analysis approaches for drug target and biomarker discovery.The company offers highly customized contract research services using advanced lentiviral technology, including custom focused and genome-wide pooled lentiviral shRNA and CRISPR sgRNA libraries, for any set of genes in any lentivector, RNAi and CRISPR genetic screenswith pooled lentiviral shRNA and CRISPR sgRNA libraries, reporter cell line development for genetic screens, custom stable CRISPR knockout and shRNA “knockdown as well as cDNA expression isogenic cell lines, and biomarker discovery using targeted PCR and NGS.
